free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • FDA Grants Miltefosine Orphan Drug Designation for Treatment of GAE americanpharmaceuticalreview
    June 29, 2017
    Profounda announced it has received the US Food and Drug Administration's Orphan Drug Designation?for the use of miltefosine to treat Granulomatous Amebic Encephalitis (GAE). Profounda licensed miltefosine (Impavido) from Knight Therapeutics.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service